Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
| Tracking Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | June 11, 2009 | ||||||||||||
| Last Updated Date | November 2, 2011 | ||||||||||||
| Start Date ICMJE | July 2009 | ||||||||||||
| Primary Completion Date | July 2010 (final data collection date for primary outcome measure) | ||||||||||||
| Current Primary Outcome Measures ICMJE |
Detectable human papilloma virus DNA in the penis, anus, or mouth [ Time Frame: Study entry ] [ Designated as safety issue: No ] | ||||||||||||
| Original Primary Outcome Measures ICMJE |
Detectable human papilloma virus DNA in the penis, anus, or mouth [ Designated as safety issue: No ] | ||||||||||||
| Change History | Complete list of historical versions of study NCT00919997 on ClinicalTrials.gov Archive Site | ||||||||||||
| Current Secondary Outcome Measures ICMJE |
|
||||||||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||||||
| Descriptive Information | |||||||||||||
| Brief Title ICMJE | Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men | ||||||||||||
| Official Title ICMJE | HPV Infection in Indian HIV-Seropositive Men Who Have Sex With Men (MSM) | ||||||||||||
| Brief Summary | RATIONALE: Gathering information about human papilloma virus (HPV) infection in HIV-positive men who have sex with men may help doctors learn more about the disease. PURPOSE: This clinical trial is studying HPV infection in HIV-positive Indian men who have sex with men. |
||||||||||||
| Detailed Description | OBJECTIVES:
OUTLINE: This is a multicenter study. Patients complete interviewer-administered questionnaires on demographics, native place, socioeconomic status, medical history, numbers of sexual partners and sexual practices, circumcision status, and risk factors for oral malignancies and human papilloma virus (HPV), including oral sex, smoking or chewing tobacco, drug use, oral hygiene, and tooth loss. Patients undergo cell sample collection from the penis, scrotum, anus, and mouth, and saliva sample collection for HPV DNA testing by PCR. Patients also undergo blood sample collection to measure CD4+ count and HIV viral load by FACS and PCR. |
||||||||||||
| Study Type ICMJE | Observational | ||||||||||||
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Prospective |
||||||||||||
| Target Follow-Up Duration | Not Provided | ||||||||||||
| Biospecimen | Retention: Samples With DNA Description: Anal cytology Penile cytology Saliva Blood |
||||||||||||
| Sampling Method | Non-Probability Sample | ||||||||||||
| Study Population | HIV-1 infected men who have sex with men from Mumbai and Vellore, India, who are age 18 or older. |
||||||||||||
| Condition ICMJE |
|
||||||||||||
| Intervention ICMJE |
|
||||||||||||
| Study Group/Cohort (s) | Specimen collection
Single group study. Blood, saliva, anal cytology, and penile cytology samples, and questionnaire responses will be collected from participants at a single study visit.
Interventions:
|
||||||||||||
| Publications * | Not Provided | ||||||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||||
| Recruitment Information | |||||||||||||
| Recruitment Status ICMJE | Completed | ||||||||||||
| Enrollment ICMJE | 302 | ||||||||||||
| Completion Date | July 2010 | ||||||||||||
| Primary Completion Date | July 2010 (final data collection date for primary outcome measure) | ||||||||||||
| Eligibility Criteria ICMJE | DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
|
||||||||||||
| Gender | Male | ||||||||||||
| Ages | 18 Years and older | ||||||||||||
| Accepts Healthy Volunteers | No | ||||||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||||||
| Location Countries ICMJE | United States | ||||||||||||
| Administrative Information | |||||||||||||
| NCT Number ICMJE | NCT00919997 | ||||||||||||
| Other Study ID Numbers ICMJE | CDR0000629624, U01CA121947, AMC-060 | ||||||||||||
| Has Data Monitoring Committee | No | ||||||||||||
| Responsible Party | AIDS Malignancy Clinical Trials Consortium | ||||||||||||
| Study Sponsor ICMJE | AIDS Malignancy Clinical Trials Consortium | ||||||||||||
| Collaborators ICMJE | National Cancer Institute (NCI) | ||||||||||||
| Investigators ICMJE |
|
||||||||||||
| Information Provided By | AIDS Malignancy Clinical Trials Consortium | ||||||||||||
| Verification Date | November 2011 | ||||||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||||||